Results for tag: "Small Volume Parenteral"

The Small Volume Parenteral (SVP) market is a segment within the healthcare services industry that focuses on the manufacture and distribution of injectable fluids used in a wide range of therapeutic areas. Small volume parenterals are typically defined as preparations with volumes of 100 milliliters or less and are used for medications that require injection, directly or diluted, into a patient. These parenteral solutions are usually administered intravenously, subcutaneously, or intramuscularly. Due to their direct delivery into the bloodstream or targeted tissues, SVPs have a rapid onset of action. They are utilized in various settings, including hospitals, clinics, and home care. Developing, producing, and ensuring the sterility and quality of SVPs is critical, as they must adhere to stringent regulatory standards. The market for SVPs encompasses a range of products including vaccines, antibiotics, antifungals, cytostatics, analgesics, and nutritional therapies. The sector is driven by technological advancements in packaging and drug delivery systems, the increasing development of biologics, and the rising demand for more convenient and efficient therapies for critical care. Several companies are active in the Small Volume Parenteral market, including Pfizer Inc., Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, and Mylan N.V. These companies engage in the development, production, and supply of SVPs, and are key players in shaping the market's dynamics through their contributions Show Less Read more